IVD Technology

March/April 2000
Selected Contents

EDITOR'S PAGE:
Heading for a molecular meltdown?

REGULATIONS AND STANDARDS:
Human tissue acquisition: New regulatory and ethical issues
by Jeffrey N. Gibbs

Development of a high-sensitivity C-reactive protein assay
by Thomas A. Luhr, Jitu Modi

The ability to measure low levels of C-reactive protein may prove to be an effective tool in predicting cardiovascular and peripheral vascular disease. An assay that can detect these low levels has recently been developed.

COVER STORY:
The place of gold in rapid tests
by John Chandler, Tracey Gurmin, and Nicola Robinson

Superior stability, sensitivity, and precision and reproducibility of manufacture make gold suitable for use in membrane-based tests.

Dealing with discrepancy analysis Part 2: Alternative analytical strategies
by Cheryl L. Hayden and Michael L. Feldstein

IVD product developers can save time and money by designing study protocols and selecting analytical methods with scientific validity uppermost in their minds.

Directory of organizations and associations

Contact information for key IVD industry organizations, associations, and government agencies